Rapamycin and Ageing: When, for How Long, and How Much?

[1]	Anderson, R.M., Weindruch, R. The caloric restriction paradigm: implications for healthy human aging Am. J. Hum. Biol., 24 (2012),pp. 101-106
[2]	Anisimov, V.N., Zabezhinski, M.A., Popovich, I.G. et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice Cell Cycle, 10 (2011),pp. 4230-4236
[3]	Bjedov, I., Toivonen, J.M., Kerr, F. et al. Cell Metab., 11 (2010),pp. 35-46
[4]	Chen, C., Liu, Y., Zheng, P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells Sci. Signal., 2 (2009),p. ra75
[5]	Ching, T.T., Paal, A.B., Mehta, A. et al. Aging Cell, 9 (2010),pp. 545-557
[6]	Fabrizio, P., Pletcher, S.D., Minois, N. et al. FEBS Lett., 557 (2004),pp. 136-142
[7]	Fabrizio, P., Pozza, F., Pletcher, S.D. et al. Regulation of longevity and stress resistance by Sch9 in yeast Science, 292 (2001),pp. 288-290
[8]	Flynn, J.M., O'Leary, M.N., Zambataro, C.A. et al. Late-life rapamycin treatment reverses age-related heart dysfunction Aging Cell, 12 (2013),pp. 851-862
[9]	Harrison, D.E., Strong, R., Sharp, Z.D. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice Nature, 460 (2009),pp. 392-395
[10]	Jia, K., Chen, D., Riddle, D.L. Development, 131 (2004),pp. 3897-3906
[11]	Johnson, S.C., Martin, G.M., Rabinovitch, P.S. et al. Preserving youth: does rapamycin deliver? Sci. Transl. Med., 5 (2013),pp. 211-240
[12]	Johnson, S.C., Rabinovitch, P.S., Kaeberlein, M. mTOR is a key modulator of ageing and age-related disease Nature, 493 (2013),pp. 338-345
[13]	Johnson, S.C., Yanos, M.E., Kayser, E.B. et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome Science, 342 (2013),pp. 1524-1528
[14]	Kaeberlein, M. Longevity and aging F1000Prime Reports, 5 (2013),p. 5
[15]	Kaeberlein, M. mTOR inhibition: from aging to autism and beyond Scientifica (Cairo), 2013 (2013),p. 849186
[16]	Kaeberlein, M., , Steffen, K.K., Westman, E.A. et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients Science, 310 (2005),pp. 1193-1196
[17]	Kapahi, P., Chen, D., Rogers, A.N. et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging Cell Metab., 11 (2010),pp. 453-465
[18]	Kapahi, P., Zid, B. TOR pathway: linking nutrient sensing to life span Science of aging knowledge environment: SAGE KE, 2004 (2004),p. PE34
[19]	Kapahi, P., Zid, B.M., Harper, T. et al. Curr. Biol., 14 (2004),pp. 885-890
[20]	Kennedy, B.K., Steffen, K.K., Kaeberlein, M. Ruminations on dietary restriction and aging Cell Mol. Life Sci., 64 (2007),pp. 1323-1328
[21]	Lamming, D.W., Ye, L., Katajisto, P. et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity Science, 335 (2012),pp. 1638-1643
[22]	Laplante, M., Sabatini, D.M. mTOR signaling in growth control and disease Cell, 149 (2012),pp. 274-293
[23]	Masoro, E.J. Overview of caloric restriction and ageing Mech. Ageing Dev., 126 (2005),pp. 913-922
[24]	Medvedik, O., Lamming, D.W., Kim, K.D. et al. PLoS Biol., 5 (2007),p. e261
[25]	Miller, R.A., Harrison, D.E., Astle, C.M. et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice J. Gerontol. A Biol. Sci. Med. Sci., 66 (2011),pp. 191-201
[26]	Miller, R.A., Harrison, D.E., Astle, C.M. et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction Aging Cell, 13 (2014),pp. 468-477
[27]	Nadon, N.L., Strong, R., Miller, R.A. et al. Design of aging intervention studies: the NIA interventions testing program Age (Dordr), 30 (2008),pp. 187-199
[28]	Neff, F., Flores-Dominguez, D., Ryan, D.P. et al. Rapamycin extends murine lifespan but has limited effects on aging J. Clin. Invest., 123 (2013),pp. 3272-3291
[29]	Pan, K.Z., Palter, J.E., Rogers, A.N. et al. Aging Cell, 6 (2007),pp. 111-119
[30]	, Kaeberlein, M., Caldwell, S.D., Kennedy, B.K. et al. Extension of chronological life span in yeast by decreased TOR pathway signaling Genes Dev., 20 (2006),pp. 174-184
[31]	Robida-Stubbs, S., Glover-Cutter, K., Lamming, D.W. et al. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO Cell Metab., 15 (2012),pp. 713-724
[32]	Selman, C., Tullet, J.M., Wieser, D. et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span Science, 326 (2009),pp. 140-144
[33]	Steffen, K.K., MacKay, V.L., Kerr, E.O. et al. Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4 Cell, 133 (2008),pp. 292-302
[34]	Vellai, T., Takacs-Vellai, K., Zhang, Y. et al. Nature, 426 (2003),p. 620
[35]	Wilkinson, J.E., Burmeister, L., Brooks, S.V. et al. Rapamycin slows aging in mice Aging Cell, 11 (2012),pp. 675-682
[36]	Zhang, Y., Bokov, A., Gelfond, J. et al. Rapamycin extends life and health in C57BL/6 mice J. Gerontol. A Biol. Sci. Med. Sci., 69 (2014),pp. 119-130
[37]	Zid, B.M., Rogers, A.N., Katewa, S.D. et al. Cell, 139 (2009),pp. 149-160